Universitat De Les Illes Balears

Lipopharma Therapeutics, S.l.

Pablo Vicente Escribá Ruiz

Xavier Busquets Xaubet

Gwendolyn Barceló Coblijn

Silvia Teres Jiménez

Victoria Lladó Cañellas

Rafael Álvarez Martínez

Daniel López

Juana Barceló Estarellas

Julian Taylor Green

Gerardo Ávila Martín

Maitane Ibarguren Aizpitarte

Amaia Marcilla Etxenike

Miguel Yus Astiz

José Javier Soto Salvador

David López Jiménez

María Antònia Noguera Salvà

María Laura Martín

Daniel Horacio LÓPEZ

Catalina Ana RosellÓ Castillo

Silvia TERÉS JIMÉNEZ

Paula FERNÁNDEZ GARCÍA

Mónica Higuera Urbano

María Antònia Noguera SalvÀ

Julián Taylor Green

Silvia Teres JIMÉNEZ

Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.

Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines

The present invention relates to hydroxy-triglycerides, their synthesis, a pharmaceutical and/or nutraceutical composition which comprises at least one of said hydroxy-triglycerides, and a method which comprises the administration to a patient of a therapeutically effective quantity of at least one of said hydroxy-triglycerides or at least one of said pharmaceutical and/or nutraceutical compositions, for the prevention and/or treatment of at least one disease selected from cancer, metabolic/cardiovascular diseases, and/or neurological/inflammatory diseases.

Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treatment of diseases

[object Object]

This invention refers to the synthesis and purification of 2 hydroxide derivatives of fatty acids, as well as to the separation method of its enantiomers (or optic isomers) [&#x2212;] y [+], to the enantiomers themselves, to pharmaceutical compositions which include them, and to their use as medicines, as well as to an in vitro method of diagnosis/prognosis and evaluation of the potential use of the molecules of the invention in different pathologies, as well as their use for the regulation of certain enzymes and the study of their activity and effects.

Enantiomers of 2-hydroxy derivatives of fatty acids

Growing community of inventors

Palma De Mallorca, Spain

Pablo Vicente Escribá Ruiz